Related Articles
The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia
Müllerian inhibiting substance/anti‑Müllerian hormone type II receptor protein and mRNA expression in the healthy and cancerous endometria
Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells
Identification of large-scale characteristic genes of Müllerian inhibiting substance in human ovarian cancer cells
Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis